Plasminogen activator inhibitor antagonists

作者: Marguerita Lim-Wilby , Edwin L. Madison , Kent E. Pryor , Joseph Edward Semple , Terence K. Brunck

DOI:

关键词:

摘要: Compounds and pharmaceutical compositions useful as plasminogen activator inhibitor (PAI) antagonists are provided. In particular, methods of antagonizing PAI with substituted unsubstituted aryl heteroaryl ethers thioethers, benzils, benzyl ethers, benzoate esters, sulfones benzophenones

参考文章(115)
M. J. Gething, B. Adler, J. A. Boose, R. D. Gerard, E. L. Madison, D. McGookey, R. S. Meidell, L. M. Roman, J. Sambrook, Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. The EMBO Journal. ,vol. 7, pp. 2731- 2740 ,(1988) , 10.1002/J.1460-2075.1988.TB03127.X
Jeffrey W. Smith, Kathy Tachias, Edwin L. Madison, Protein Loop Grafting to Construct a Variant of Tissue-type Plasminogen Activator That Binds Platelet Integrin αIIbβ3 Journal of Biological Chemistry. ,vol. 270, pp. 30486- 30490 ,(1995) , 10.1074/JBC.270.51.30486
Karl Dr. Eicken, Gisela Dr. Lorenz, Thomas Dr. Zierke, Eberhard Dr. Ammermann, Bernd Dr. Janssen, Thomas Dr. Müller, Method of control of fungi ,(1992)